Andreas H. Scheel
University of Cologne(DE)Evotec (Germany)(DE)University Hospital Cologne(DE)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Peptidase Inhibition and Analysis, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics
Most-Cited Works
- → Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas(2016)347 cited
- → Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors(2016)261 cited
- → K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways(2018)251 cited
- → PD-L1 expression in small cell neuroendocrine carcinomas(2015)237 cited
- → “Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy(2019)175 cited
- → Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors(2018)139 cited